Your browser doesn't support javascript.
loading
Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
Wurster, K D; Hummel, F; Richter, J; Giefing, M; Hartmann, S; Hansmann, M-L; Kreher, S; Köchert, K; Krappmann, D; Klapper, W; Hummel, M; Wenzel, S-S; Lenz, G; Janz, M; Dörken, B; Siebert, R; Mathas, S.
Afiliação
  • Wurster KD; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Hummel F; Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Richter J; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Giefing M; Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Hartmann S; Institute of Human Genetics, Christian-Albrechts University Kiel, Kiel, Germany.
  • Hansmann ML; Institute of Human Genetics, Christian-Albrechts University Kiel, Kiel, Germany.
  • Kreher S; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
  • Köchert K; Dr Senckenberg Institute of Pathology, University of Frankfurt, Medical School, Frankfurt, Germany.
  • Krappmann D; Dr Senckenberg Institute of Pathology, University of Frankfurt, Medical School, Frankfurt, Germany.
  • Klapper W; Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Hummel M; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Wenzel SS; Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Lenz G; Research Unit Cellular Signal Integration, Helmholtz Zentrum München für Gesundheit und Umwelt, Neuherberg, Germany.
  • Janz M; Department of Pathology, Haematopathology Section and Lymph Node Registry, Christian-Albrechts University Kiel, Kiel, Germany.
  • Dörken B; Institute of Pathology, Charité-Universitätsmedzin Berlin, Berlin, Germany.
  • Siebert R; Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Mathas S; Division of Translational Oncology, Department of Medicine A, University Hospital Münster, and Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany.
Leukemia ; 31(3): 602-613, 2017 03.
Article em En | MEDLINE | ID: mdl-27538486
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Regulação Neoplásica da Expressão Gênica / Linfoma Anaplásico de Células Grandes / Proteínas com Domínio LIM / Proteínas dos Microfilamentos Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Regulação Neoplásica da Expressão Gênica / Linfoma Anaplásico de Células Grandes / Proteínas com Domínio LIM / Proteínas dos Microfilamentos Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article